文献速递细菌感染、耐药与抗菌药物医院感染防控

IMP碳青霉烯酶与非产酶肠杆菌科细菌感染的多中心前瞻性临床与分子流行病学比较

Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

该多中心前瞻性研究纳入2016年8月至2018年3月分离出碳青霉烯耐药肠杆菌科细菌(CRE)的患者,比较产IMP碳青霉烯酶肠杆菌科细菌(CPE)与非产酶菌(non-CPE)的临床与微生物学特征。结果显示CPE组耐药更频繁,独立预测因素包括养老院居住、较长既往住院时间、尿管或鼻胃管使用、功能依赖状态及碳青霉烯暴露;两组院内及30天死亡率相似,但CPE组CRE分离后住院时间更长。

要点

  • IMP-CPE较non-CPE耐药更频繁,耐药基因携带更多。
  • 养老院居住、长住院时间、导管使用、功能依赖及碳青霉烯暴露预测CPE分离。
  • 两组死亡率相似,但CPE组CRE分离后住院时间更长。

核心结论

  • IMP-CPE与住院时间延长相关,且临床和微生物学特征与非CPE不同。
  • 对IMP-CPE和非CPE需采取针对性的研究、公共卫生报告及临床和感染预防措施。

研究设计与样本

  • 多中心前瞻性研究,纳入2016年8月至2018年3月分离出CRE(美罗培南MIC≥2 mg/L、亚胺培南≥2 mg/L或头孢美唑≥64 mg/L)的患者。
  • 进行微生物学分析和全基因组测序(WGS),比较组间临床参数,采用logistic回归识别CPE分离的独立预测因素,并使用稳定逆概率加权法进行倾向评分调整分析比较临床结局。

主要发现

  • 所有CPE分离株均检测为IMP碳青霉烯酶阳性。
  • CPE组抗生素耐药(及耐药基因存在)比non-CPE组更频繁。
  • CPE分离的独立预测因素包括养老院或长期护理机构居住、较长既往住院时间(LOS)、使用尿管和/或鼻胃管、功能依赖状态及碳青霉烯暴露。
  • 两组院内和30天死亡率相似,但CPE组CRE分离后住院时间更长。

临床怎么用

  • 对具有养老院居住、长住院时间、导管使用、功能依赖及碳青霉烯暴露等风险因素的患者,应警惕IMP-CPE感染。
  • 临床和感染预防上需区分IMP-CPE与非CPE,采取针对性措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) are classified as carbapenemase-producing Enterobacteriaceae (CPE) and non-CPE; the majority of CPE in Japan produce IMP carbapenemase. OBJECTIVES: We evaluated the clinico-epidemiological and microbiological information and effects of IMP-type carbapenemase production in CRE. METHODS: Patients with isolations of CRE (MICs of meropenem ≥2 mg/L, imipenem ≥2 mg/L or cefmetazole ≥64 mg/L) from August 2016 to March 2018 were included. Microbiological analyses and WGS were conducted and clinical parameters were compared between groups. Independent predictors for the isolation of CPE from patients were identified by logistic regression. For comparing clinical outcomes, a stabilized inverse probability weighting method was used to conduct propensity score-adjusted analysis. RESULTS: Ninety isolates (27 CPE and 63 non-CPE) were collected from 88 patients (25 CPE and 63 non-CPE). All CPE tested positive for IMP carbapenemase. Antibiotic resistance (and the presence of resistance genes) was more frequent in the CPE group than in the non-CPE group. Independent predictors for CPE isolation were residence in a nursing home or long-term care facility, longer prior length of hospital stay (LOS), use of a urinary catheter and/or nasogastric tube, dependent functional status and exposure to carbapenem. Although in-hospital and 30 day mortality rates were similar between the two groups, LOS after CRE isolation was longer in the CPE group. CONCLUSIONS: IMP-CPE were associated with prolonged hospital stays and had different clinical and microbiological characteristics compared with non-CPE. Tailored approaches are necessary for the investigational and public health reporting, and clinical and infection prevention perspectives for IMP-CPE and non-CPE.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Hayakawa K, Nakano R, Hase R, et al. Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae. J Antimicrob Chemother. 2020. PMID: 31789374. doi:10.1093/jac/dkz501

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。